OCTAVIA GRANT
AUTHOR

OCTAVIA GRANT

Tap the gear icon above to manage new release emails.
Octavia Grant discovered her passion for creative writing in 2002 during her junior year at Georgetown High School in Georgetown, South Carolina. She began writing professionally in 2016 and, two years later, took full ownership of her literary career by becoming an independent author. A bestselling black thriller author and the bestselling author of Cutthroat, Octavia has penned more than 30 novels known for their psychological depth and gripping suspense.
Her work and voice have earned national recognition, including speaking on the Thrilling Tales Author Panel at ESSENCE Fest, Thriller Panelist at National Book Club Conference (NBCC), interview with Narrator iiKane, literary reviewer and film commentator Tamara Walker of Tam Telling Tales, and features in WYB Lifestyle, VoyageJacksonville, Canvas Rebel, and Bold Journey. She has also been honored as one of 160 Black Women in Horror and received multiple accolades for her psychological thriller novella Dear Vicky, including the Black Girls Who Write It’s Lit Award for Best Black Mystery/Suspense, the Audio in Black North Star Award, and the AAMBC Award for Mystery/Thriller Book of the Year.
In addition to these achievements, Octavia has been named Best Thriller/Suspense Horror Author by the Literary Gem Awards and Best Female Author by the Get Caught Up Podcast. Her storytelling continues to push boundaries within the thriller genre, centering bold narratives that captivate, challenge, and resonate with readers worldwide.


Octavia loves reader interaction and encourages her readers to follow her on social media:

FB: Author Octavia Grant
IG: Author Octavia Grant
TikTok:Author Octavia Grant
Twitter: Author_Octavia
Read more Read less

Best Sellers

Product List
  • I'll Never Let You Go cover art
    Preview

    ₹721.09 or free with 30-day trial

    Free with 30-day trial
  • Ruthless Behavior cover art
    Preview

    ₹546.23 or free with 30-day trial

    Free with 30-day trial